A coronavirus vaccine developed by Pfizer and BioNTech has arrived in the UK. The vaccination campaign will start next week with the first shipment.
The vaccine was trucked from Belgium via the Channel Tunnel to England late Thursday evening. The shipment of vaccine was transferred from the English station to a distribution center, the location of which was not disclosed by the British government.
Downing Street reported that the truck carrying the vaccine did not have any markings indicating the nature of the shipment.
The British Medicines Agency (MHRA) announced the previous day that it had authorized the marketing of the Pfizer / BioNTech vaccine. Thus, the United Kingdom is the first country in the world to give official approval for a Coronavirus vaccine. The British government plans to launch a vaccination campaign in the United Kingdom next Tuesday, with 800,000 doses of the vaccine available in the first round.
London has so far ordered 40 million doses of the Pfizer / BioNTech vaccine. Matt Hancock According to Britain’s health secretary, millions of those will arrive as early as December. The UK Pharmacovigilance Authority recently launched a licensing process for a coronavirus vaccine jointly developed by the British-Swedish pharmaceutical group AstraZeneca and the University of Oxford. The British government has requested 100 million doses of this vaccine.
The British Government’s Joint Commission on Vaccination and Immunization (JCVI) has developed a list of priorities in the order in which each population can get the vaccine.
According to the 25-page guide, nursing home residents and their caregivers top the list. They are followed by those over the age of 80 and those working on the front lines of healthcare and nursing services, followed in chronological order of 75, 70, 65, 60, 55, and finally over 50. The group of people over the age of 65 includes those of the ages. Between 16 and 64 years old and those with a chronic underlying disease have an increased risk of serious complications or death from coronavirus infection. (MTI)